Sean Laaman

Stock Analyst at Morgan Stanley

(2.22)
# 1032
Out of 5,372 analysts
3
Total ratings
50.00%
Success rate
45.89%
Average return
3 Stocks
Name Action PT Current % Upside Ratings Updated
ALEC Alector
Assumes: Underweight
3 2
1.53 -1.96% 1 Mar 7, 2025
BGNE BeiGene
Assumes: Overweight
300
n/a n/a 1 Dec 3, 2024
RMD ResMed
Upgrades: Overweight
169
249.91 -32.38% 1 Oct 27, 2023